Singapore markets closed

Straits Times Index
3,246.33
-13.70(-0.42%)
Nikkei
26,717.34
+547.04(+2.09%)
Hang Seng
23,550.08
-256.92(-1.08%)
FTSE 100
7,466.07
-88.24(-1.17%)
BTC-USD
37,796.50
+630.26(+1.70%)
CMC Crypto 200
863.83
+21.37(+2.54%)

Genting HK ex-chairman Lim Kok Thay blames Germany for cruise operator’s demise

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD

Add to watchlist

45.25

-0.49

(-1.07%)

At close: 04:00PM EST

45.24

-0.01

(-0.02%)

After hours:

07:41PM EST

Trade prices are not sourced from all markets

News

Zacks
GlaxoSmithKline (GSK) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, GlaxoSmithKline (GSK) closed at $45.25, marking a -1.07% move from the previous day.
Motley Fool
Should GlaxoSmithKline Have Accepted Unilever's $68 Billion Consumer Health Offer?
In this Motley Fool Live video recorded on Jan. 19, Motley Fool contributors Keith Speights and Brian Orelli discuss whether they think GlaxoSmithKline should have accepted Unilever's offer. Keith Speights: One of the big stories in recent days was that GlaxoSmithKline (NYSE: GSK) revealed that it turned down an offer of more than $68 billion from Unilever (NYSE: UL) to buy the combined consumer health unit of Glaxo and Pfizer (NYSE: PFE).
Zacks
Gilead's (GILD) Magrolimab Studies Put on Hold by the FDA
Gilead (GILD) efforts to build an oncology franchise get jolted as the FDA places hold on a few studies evaluating the combination of magrolimab plus azacitidine.